Portfolio company
CureSign
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This medical device company develops implantable sensors and data analytics to monitor cancer treatment efficacy for oncologists and clinical teams.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Coherence
This company develops minimally invasive implants and neurotechnology to monitor and manage cancer via real-time electrical signaling for patients with aggressive tumours.
HEPTA Medical
This company develops a microwave ablation platform with integrated temperature sensors for clinicians to treat early-stage lung cancer patients using minimally invasive procedures.
Sensible Healthcare Systems
This company develops reusable continuous glucose monitoring sensors for people living with diabetes.
Oncobit
This company develops precision diagnostic assays and cloud-based monitoring software for clinicians to track cancer markers and therapy response in oncology patients.
Neurolase
This company develops a handheld laser device using artificial intelligence to help neurosurgeons identify cancerous brain tissue in real time during surgery.
Luminate Medical
This company develops wearable medical devices to prevent chemotherapy side effects and facilitate at-home cancer treatment for oncology patients and healthcare providers.
Entia
This company develops at-home blood monitoring devices for cancer patients to share results with healthcare providers and improve treatment management.
Sensys
This company develops non-invasive blood glucose monitors using infrared spectroscopy for patients managing diabetes.
